After four years of collaboration, a consortium of 25 Boston-area scientists has mapped the proteins in the mitochondria—which provides a cell’s chemical energy—of five disease-causing parasites. The researchers say the results, which were recently published across nine papers in Cell and related journals, have the potential to inspire new medicines, known as pan-parasitic drugs, to treat multiple neglected diseases.
The group included a team of Boston University researchers, led by Inna Afasizheva, John Samuelson, and Ruslan Afasizhev, all members of the Henry M. Goldman School of Dental Medicine’s Department of Molecular and Cell Biology. According to Afasizhev, the work “represents a major scientific achievement.”
The parasites the consortium studied reportedly affect hundreds of millions of people worldwide every year, causing issues as diverse as red blood cell destruction, flu-like symptoms, and vision loss. Samuelson led the group’s work on the parasites Acanthamoeba castellanii (which can infect the eye and lead to blindness) and Giardia duodenalis (which can cause diarrheal disease); Afasizhev and Afasizheva spearheaded research on Leishmania (which causes leishmaniasis, with symptoms ranging from skin lesions to potentially fatal visceral disease) and Trypanosoma (responsible for African sleeping sickness and Chagas disease). As well as parasites, the consortium’s researchers also analyzed Arabidopsis, a flowering plant often studied by biologists because of its small genome and rapid life cycle.
